金属硫蛋白和瑞舒伐他汀对小鼠动脉粥样硬化和SM22α表达的影响

doi:10.3969/j.issn.1674-5817.2014.06.004

实验动物与比较医学 ›› 2014, Vol. 34 ›› Issue (6): 449-453.DOI: 10.3969/j.issn.1674-5817.2014.06.004

金属硫蛋白和瑞舒伐他汀对小鼠动脉粥样硬化和SM22α表达的影响

朱中生¹, 鲁亚丽²

1.徐州市第一人民医院心内科, 徐州 221002;
2.南京医科大学附属南京第一医院心内科, 南京 210006

收稿日期:2014-06-19 出版日期:2014-12-25 发布日期:2014-12-25
作者简介:朱中生(1969-), 男, 医学博士, 主要从事冠心病的发病机制和治疗研究, E-mail:drzzs66@163.com

Effect of Metallothionein and Rosuvastatin on Atherosclerosis and SM22α Expression in ApoE-deficient Mice

ZHU Zhong-sheng¹, LU Ya-li²

1. Cardiology Department, Xuzhou First People’s Hospital, Xuzhou 221002, China;
2. Cardiology Department, Nanjing First Hospital of Nanjing Medical University, Nanjing 210006, China

Received:2014-06-19 Online:2014-12-25 Published:2014-12-25

摘要/Abstract

摘要： 目的探讨金属硫蛋白(MT)和HMG-CoA还原酶抑制剂瑞舒伐他汀对ApoE基因缺陷小鼠动脉粥样硬化以及血管平滑肌22 α蛋白(SM22α)表达的影响。方法 30只6周龄雄性ApoE基因缺陷小鼠随机分为高脂模型组、瑞舒伐他汀组、金属硫蛋白组,高脂饮食喂养13周;10只背景品系雄性C57BL/6J小鼠作为正常对照组,正常饮食喂养13周。13周后,摘眼球取血测定血浆总胆固醇(TCH)、甘油三酯(TG)、低密度脂蛋白(LDL-C)的水平,处死小鼠后取主动脉,剪取主动脉弓部位5 mm长主动脉用10％甲醛固定,石蜡包埋,切片,HE染色及SM22α免疫组织化学染色;其余标本-80 ℃保存,取100 mg主动脉组织两份,分别提取总蛋白和RNA,并做Western Blot 和RT-PCR检测,观察主动脉血管壁形态学变化,定性和定量分析主动脉组织SM22α表达强度变化。结果与高脂模型组比较,瑞舒伐他汀组血清中TCH、TG、LDL-C水平显著降低 (P<0.05); 金属硫蛋白组与高脂高脂模型组比较,TCH、TG、LDL-C水平无统计学差异(P>0.05); 和正常对照组相比,高脂模型组主动脉粥样硬化病变程度明显加重,免疫组织化学、Western Blot和RT-PCR方法分析主动脉SM22α蛋白和mRNA的表达均明显减少;金属硫蛋白和瑞舒伐他汀组主动脉粥样硬化病变程度减轻,SM22α蛋白和mRNA的表达均增加。结论金属硫蛋白对血脂无明显影响,瑞舒伐他汀降低血脂作用明显;ApoE基因缺陷小鼠主动脉组织动脉粥样硬化明显且SM22α表达减少,金属硫蛋白和瑞舒伐他汀可减轻主动脉粥样硬化病变程度并可增加主动脉SM22α的表达。

关键词: 金属硫蛋白(MT), 瑞舒伐他汀, ApoE基因缺陷小鼠, 动脉粥样硬化(AS), 平滑肌22α蛋白

Abstract: Objective To research the effect of metallothionein(MT) and rosuvastatin on atherosclerosis and smooth muscle 22 alpha (SM22α) expression in ApoE-deficient mice. Methods Thirty 6-week-old ApoE- deficient male mice were divided into hyperlipidemia model group, rosuvastatin group, and MT group randomly, fed with fatty diet for 13 weeks. Ten background strain C57BL/6J (wild type) male mice were selected as normal control group,and fed with normal diet for 13 weeks. After 13 weeks, eyeballs were extracted and blood was taken from ApoE-deficient mice for detecting lipid profile, then the mice were executed and the aortas were dissociated, 5 mm vessel in aorta arch were taken and fixed in 10% formalin, then treated with paraffin imbedding, slicing, HE staining and SM22α immunohistochemistry staining; some specimen was preserved in -80 ℃ refrigerator, total protein and RNA were extracted, West Blot and RT-PCR were taken.To observe morphology changes of aortic wall, to analyse SM22α expression intensity of aorta tissue qualitatively and quantitively. Results The blood lipid level in rosuvastation group was lower than that in hyperlipidemia model group (P<0.05). There is no difference in the blood lipid level between MT group and hyperlipidemia model group (P>0.05). Compared with normal control group, intimal thickness, plaque volume increased and SM22α protein and mRNA expression decreased in hyperlipidemia model group. Compared with hyperlipidemia model group, intimal thickness, plaque volume decreased and SM22α protein and mRNA expression increased in MT and rovustatin group. Conclusion The MT has no effect on lipid profile, rovustatin can lower blood lipid obviously. MT and rovustatin can alleviate atherosclerosis lesions and increase SM22α protein and mRNA expression in aorta of ApoE-deficient mice. Their anti-athrosclerosis effect is related to up regulating SM22α expression.

Key words: Metallothionein, Rosavastation, ApoE-deficient mice, Atherosclerosis, SM22α

中图分类号:

Q95-33

朱中生, 鲁亚丽. 金属硫蛋白和瑞舒伐他汀对小鼠动脉粥样硬化和SM22α表达的影响[J]. 实验动物与比较医学, 2014, 34(6): 449-453.

ZHU Zhong-sheng, LU Ya-li. Effect of Metallothionein and Rosuvastatin on Atherosclerosis and SM22α Expression in ApoE-deficient Mice[J]. Laboratory Animal and Comparative Medicine, 2014, 34(6): 449-453.

参考文献

[1] Diaz-Ruiz A, Vacio-Adame P, Monroy-Noyola A, et al.Metallothionein-II inhibits lipid peroxidation and improves functional recovery after transient brain ischemia and reperfusion in rats[J]. Oxid Med Cell Longev, 2014, 436429. doi: 10.1155/2014/436429. Epub 2014 Feb 25.
[2] Arai H.Oxidative modification of lipoproteins[J]. Subcell Biochem, 2014, 77:103-114.
[3] Lv P, Miao SB, Shu YN, et al.Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo[J]. Circ Res, 2012, 111(6):697-707.
[4] Desjardins F, Sekkali B, Verreth W, et al.Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice[J]. Eur Heart J, 2008, 29(1):128-137.
[5] Tanaka T, Sato H, Doi H, et al. Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells [J]. Mol Cell Biol, 2008, 28(3):1147-1160.
[6] Won KJ, Lee HM, Lee CK, et al.Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway[J]. J Pharmacol Sci, 2011, 115(2):164-175.
[7] Cherian MG.Metabolism of orally administered cadmium-metallothionein in mice[J]. Environ Health Perspect, 1979, 28:127-130.
[8] Wamhoff BR, Hoofnagle MH, Burns A, et al.A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis[J]. Circ Res, 2004, 95(10): 981-988.
[9] 程云会, 韩梅, 温进坤, 等. 收缩蛋白在血管新生内膜形成过程中的表达变化及其对血管收缩力的影响[J].中国病理生理杂志, 2005, 21(11):21l1-2l15.
[10] Chen R, Zhang F, Song L, et al.Transcriptome profiling reveals that the SM22α-regulated molecular pathways contribute to vascular pathology[J]. J Mol Cell Cardiol, 2014, 72: 263-272.

金属硫蛋白和瑞舒伐他汀对小鼠动脉粥样硬化和SM22α表达的影响

Effect of Metallothionein and Rosuvastatin on Atherosclerosis and SM22α Expression in ApoE-deficient Mice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

[1]	许振坤, 任丽玮, 原涛. 高脂饲喂结合颈总动脉球囊损伤制作胰岛素抵抗兔动脉粥样硬化模型[J]. 实验动物与比较医学, 2020, 40(1): 28-32.
[2]	孙理华, 张颖, 曹桂秋, 李鹏, 胡强, 张雅玲, 幸世峰. 循环内皮微粒相关microRNA在巨噬细胞炎性反应诱发小鼠动脉粥样硬化发生的机制[J]. 实验动物与比较医学, 2019, 39(3): 201-207.
[3]	陈民利. 西藏小型猪和五指山小型猪的生理特点及其动脉粥样硬化的发病特征比较研究[J]. 实验动物与比较医学, 2018, 38(5): 325-328.
[4]	张梅英, 杨葳, 吴红联, 董婉维, 周生来, 于洋, 王惟, 郭晓冲, 郑志红. 5-脂氧化酶转基因小鼠表型初步研究[J]. 实验动物与比较医学, 2015, 35(4): 265-270.
[5]	斯徐伟, 奚赛飞, 徐孝平, 诸葛福媛, 陈小真, 蔡月琴, 陈民利. ZDF与SD大鼠动脉粥样硬化形成及其磷脂酶A2表达的比较研究[J]. 实验动物与比较医学, 2015, 35(1): 10-16.